Related Experiment Video

Updated: May 27, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest

P Russell1, B T Hennessy, J Li

  • 1University of Cambridge, Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Cambridge, UK.

Oncogene
|November 8, 2011
PubMed

Insights

Cyclin G1 (CCNG1) regulates cell fate after mitotic arrest induced by taxane chemotherapy. High CCNG1 promotes survival, while low CCNG1 enhances cancer cell death, impacting patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Taxane chemotherapy activates the spindle assembly checkpoint (SAC) to arrest mitosis.
  • Taxane-treated cells eventually undergo mitotic slippage, leading to either survival or apoptosis.
  • Mechanisms determining cell fate after SAC arrest remain largely unknown.

Purpose of the Study:

  • To investigate the role of cyclin G1 (CCNG1) in regulating cell fate following taxane-induced mitotic arrest.
  • To elucidate the impact of CCNG1 on mitotic slippage and apoptosis in cancer cells.

Main Methods:

  • Analysis of CCNG1 expression in paclitaxel-treated cells.
  • Manipulation of CCNG1 levels using RNA interference.
  • Assessment of mitotic slippage and apoptosis.
  • Correlation of CCNG1 amplification with patient survival data.

Main Results:

  • CCNG1 expression increases during paclitaxel-induced, SAC-mediated mitotic arrest.
  • CCNG1 overexpression promotes cell survival after paclitaxel treatment.
  • CCNG1 depletion delays slippage and enhances paclitaxel-induced apoptosis.
  • CCNG1 amplification correlates with shorter survival in ovarian cancer patients treated with taxanes and platinum compounds.

Conclusions:

  • CCNG1 plays a critical role in determining cell fate after taxane-induced mitotic arrest.
  • CCNG1 regulates mitotic slippage and the balance between cell survival and apoptosis.
  • CCNG1 may represent a therapeutic target for improving taxane efficacy in cancer treatment.

More Related Videos

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.